Xgeva and Urination - excessive volume - a phase IV clinical study of FDA data

Summary:

Urination - excessive volume is reported as a side effect among people who take Xgeva (denosumab), especially for people who are female, 60+ old, also take Letrozole, and have Breakthrough pain.

The phase IV clinical study analyzes which people have Urination - excessive volume when taking Xgeva. It is created by eHealthMe based on reports of 37,636 people who have side effects when taking Xgeva from the FDA, and is updated regularly.

What is Xgeva?

Xgeva has active ingredients of denosumab. It is often used in breast cancer. eHealthMe is studying from 37,717 Xgeva users. Check the latest studies of Xgeva.

What is Urination - excessive volume?

Urination - excessive volume is found to be associated with 928 drugs and 1,309 conditions by eHealthMe. Check the latest studies of Urination - excessive volume.

On Jul, 11, 2026

37,636 people reported to have side effects when taking Xgeva.
Among them, 13 people (0.03%) have Urination - excessive volume.

Could Xgeva cause Urination - excessive volume?

Among these 13 people:

What is the gender of people who have Urination - excessive volume when taking Xgeva? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Urination - excessive volume when taking Xgeva? *

What are other drugs people take besides Xgeva? *

What are other side effects people have besides Urination - excessive volume? *

Back Pain: 2 people, 15.38%
Fall: 2 people, 15.38%
Dizziness: 2 people, 15.38%
Malignant Neoplasm Progression (cancer tumour came back): 2 people, 15.38%
Weight Decreased: 1 person, 7.69%
Disease Progression: 1 person, 7.69%
Hyperhidrosis (abnormally increased sweating): 1 person, 7.69%
Haematuria (presence of blood in urine): 1 person, 7.69%
Gynecomastia (enlargement of the gland tissue of the male breast): 1 person, 7.69%
Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 1 person, 7.69%

What are the existing conditions these people have? *

Tumor: 1 person, 7.69%
Sleep Disorder: 1 person, 7.69%
Prostate Cancer Metastatic: 1 person, 7.69%
Nausea (feeling of having an urge to vomit): 1 person, 7.69%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 7.69%
Lung Carcinoma Cell Type Unspecified Stage Iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver): 1 person, 7.69%
Breakthrough Pain: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Xgeva and have Urination - excessive volume?

- Check whether Urination - excessive volume is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xgeva:

Xgeva (37,717 reports)

Browse all side effects of Xgeva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urination - excessive volume:

Urination - excessive volume (928 drugs)

Browse all the conditions that are associated with Urination - excessive volume:

Urination - excessive volume (1,309 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on denosumab (the active ingredients of Xgeva) and Xgeva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.